A new diagnostic marker for alzheimer disease?
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:

Access through your institution Buy or subscribe Elevated β-synuclein levels in the cerebrospinal fluid (CSF) could be an early indicator of Alzheimer disease (AD), according to new
research. Using a novel ELISA, researchers detected increased CSF β-synuclein levels in patients with mild cognitive impairment, AD dementia or Creutzfeldt–Jakob disease, but not in other
neurological conditions such as Parkinson disease and amyotrophic lateral sclerosis. β-Synuclein localizes to glutamatergic synapses in the brain, and its presence in the CSF could be an
early sign of AD-associated synaptic degeneration. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Access Nature and 54
other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12 print issues and
online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes
which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES ORIGINAL ARTICLE *
Halbgebauer, S. et al. Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease. _J. Neurol. Neurosurg. Psychiatry_ https://doi.org/10.1136/jnnp-2020-324306
(2020) Article PubMed Google Scholar Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Nature Reviews Neurology http://www.nature.com/nrneurol/ Heather Wood Authors *
Heather Wood View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Heather Wood. RIGHTS AND PERMISSIONS Reprints and
permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Wood, H. A new diagnostic marker for Alzheimer disease?. _Nat Rev Neurol_ 17, 64 (2021). https://doi.org/10.1038/s41582-021-00458-z Download
citation * Published: 11 January 2021 * Issue Date: February 2021 * DOI: https://doi.org/10.1038/s41582-021-00458-z SHARE THIS ARTICLE Anyone you share the following link with will be able
to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing
initiative